Prevalence and risk factors for uveitis in spondyloarthritis

Aim To determine the prevalence and risk factors for uveitis in spondyloarthritis (SpA) patients. Methods A total of 225 patients who fulfilled Assessment of Spondyloarthritis International Society classification criteria for axial and peripheral SpA were enrolled. The diagnosis of uveitis was confirmed by an ophthalmologist. From medical records and from clinical evaluation associated information like disease duration, and human leukocyte antigen B27 was collected. Relevant laboratory tests were done and disease severity was assessed using Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Ankylosing Spondylitis Disease Activity Score - erythrocyte sedimentation rate and C-reactive protein. Characteristics of uveitis positive and uveitis negative groups were compared. Multivariate logistic regression analysis was done for the risk factors, and P values Prevalence of uveitis was 18.7%. The disease duration was 9.3 +/- 7 years and 5.4 +/- 4.5 years in uveitis and no uveitis groups respectively (P <= .001). Family history of SpA was positive in 45.2% in the uveitis group (P <= .001). The frequency of axial SpA was 92.9% and 73.8% in the uveitis and no uveitis groups respectively (P <= .008). The mean BASDAI was 2.4 +/- 1.9 and 3.3 +/- 2.8 in uveitis and no uveitis groups respectively (P = .050). In multivariate logistic regression analysis, among the selected variables, family history of SpA (odds ratio [OR] =3.697; 95% CI =1.616-8.457; P = .002) and duration of disease (OR =1.089; 95% CI =1.004-1.181; P = .039) were independently associated with the occurrence of uveitis. Conclusions The prevalence of uveitis was 18.7%. The family history and the disease duration of SpA were independently associated with uveitis.